Erasca Inc. (ERAS) NASDAQ

$2.05 (0.01) (-0.48%)

Market Cap: $311.24M

As of 03/28/24 03:59 PM EDT. Market closed.

(ERAS)

Erasca Inc. (ERAS)
NASDAQ

$2.05
(0.01) (-0.48%)

Market Cap: $311.24M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with ... read more

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jonathan E. Lim
Full Time Employees
131
URL
Address
10835 Road to the Cure, Suite 140, CA, San Diego, 92121.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jonathan E. Lim
Full Time Employees
131
Address
10835 Road to the Cure, Suite 140, CA, San Diego, 92121.
PRICE CHART FOR ERASCA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.19
Previous Close
$2.06
Days Range
$1.98 - $2.08
52 week range
$1.51 - $3.38
Volume
1,900,231
Avg. Volume (30 days)
752,950
Market Cap
$311.24M
Dividend Yield
-
P/E
-
Shares Outstanding
151,087,038
Open
$2.19
Previous Close
$2.06
Days Range
$1.98 - $2.08
52 week range
$1.51 - $3.38
Volume
1,900,231
Avg. Volume (30 days)
752,950
Market Cap
$311.24M
Dividend Yield
-
P/E
-
Shares Outstanding
151,087,038
FINANCIAL STATEMENTS FOR ERASCA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ERASCA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Chacko David M.CFO and CBODec 15, 2023 Option Exercise$1.597,47811,886246,726Dec 18, 2023, 09:14 AM
Garner EbunGeneral Counsel & Corp. Sec.Dec 15, 2023 Option Exercise$1.595,4488,6609,728Dec 18, 2023, 09:13 AM
Start Valerie Denise HardingDirectorDec 06, 2023 Buy$1.8510,00018,48020,000Dec 08, 2023, 09:10 AM
Lim Jonathan EChairman & CEODec 06, 2023 Buy$1.72278,150478,41812,899,360Dec 06, 2023, 07:41 PM
Lim Jonathan EChairman & CEODec 05, 2023 Buy$1.69721,8501,217,76112,899,360Dec 06, 2023, 07:41 PM
Casdin Alexander W.DirectorDec 04, 2023 Buy$1.6630,00049,785493,974Dec 04, 2023, 06:23 PM
Lim Jonathan EChairman & CEOOct 05, 2023 Buy$2.031,000,0002,026,00019,456,216Oct 10, 2023, 08:00 AM
Lim Jonathan EChairman & CEOJun 08, 2023 Buy$2.75100,000275,00018,396,216Jun 08, 2023, 08:54 PM
Casdin Alexander W.DirectorApr 10, 2023 Buy$2.7620,00055,230463,974Apr 11, 2023, 08:23 AM
Lim Jonathan EChairman & CEOMar 28, 2023 Buy$2.84100,000284,00018,296,216Mar 28, 2023, 09:24 PM
Chacko David M.Chief Financial OfficerFeb 01, 2023 Option Exercise$4.101,7507,169239,248Feb 03, 2023, 08:54 AM
Wei LinChief Medical OfficerFeb 01, 2023 Option Exercise$4.101,7507,169315,812Feb 03, 2023, 08:53 AM
Garner EbunGeneral Counsel & Corp. Sec.Feb 01, 2023 Option Exercise$4.102,3909,7914,280Feb 03, 2023, 08:53 AM
Lim Jonathan EChairman & CEOJan 10, 2023 Buy$3.8660,000231,42020,256,222Jan 10, 2023, 04:46 PM
Start Valerie Denise HardingDirectorDec 21, 2022 Buy$4.6410,00046,40010,000Dec 22, 2022, 09:28 PM
Bristol James ArthurDirectorDec 21, 2022 Buy$4.1420,00082,80020,000Dec 22, 2022, 09:26 PM
Chen BihuaDirectorDec 13, 2022 Buy$6.50307,6921,999,99810,813,246Dec 21, 2022, 04:33 PM
Chen BihuaDirectorDec 13, 2022 Buy$6.50307,6921,999,99810,813,246Dec 20, 2022, 05:42 PM
Casdin Alexander W.DirectorDec 15, 2022 Buy$4.8720,00097,490443,974Dec 15, 2022, 04:47 PM
Lim Jonathan EChairman & CEODec 14, 2022 Buy$4.9940,000199,60020,196,222Dec 15, 2022, 11:53 AM
Garner EbunGeneral Counsel & Corp. Sec.Feb 01, 2022 Option Exercise$11.6099011,4861,890Feb 03, 2022, 07:56 PM
Wei LinChief Medical OfficerFeb 01, 2022 Option Exercise$11.601,56218,123314,062Feb 03, 2022, 07:54 PM
Chacko David M.Chief Financial OfficerFeb 01, 2022 Option Exercise$11.601,56218,123237,498Feb 03, 2022, 07:39 PM
Chen BihuaDirectorAug 10, 2021 Buy$22.10200,0004,420,00010,505,553Aug 10, 2021, 04:02 PM
Chen BihuaDirectorJul 26, 2021 Sale$18.76200,0003,753,00010,305,553Aug 10, 2021, 04:02 PM
Chen BihuaDirectorJul 20, 2021 Buy$16.00950,00015,200,00010,505,553Jul 22, 2021, 04:10 PM
Garner EbunGeneral CounselJul 20, 2021 Buy$16.0090014,400900Jul 20, 2021, 08:57 PM
Start Valerie Denise HardingDirectorJul 20, 2021 Buy$16.002,00032,0002,000Jul 20, 2021, 08:49 PM
Multani Pratik SDirectorJul 20, 2021 Buy$16.006,20099,200172,866Jul 20, 2021, 08:46 PM
Hambleton JulieDirectorJul 20, 2021 Buy$16.006,00096,0006,000Jul 20, 2021, 08:43 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Chacko David M.CFO and CBO12/15/202311,886
Garner EbunGeneral Counsel & Corp. Sec.12/15/20238,660
Start Valerie Denise HardingDirector12/06/202318,480
Lim Jonathan EChairman & CEO12/06/2023478,418
Lim Jonathan EChairman & CEO12/05/20231,217,761
Casdin Alexander W.Director12/04/202349,785
Lim Jonathan EChairman & CEO10/05/20232,026,000
Lim Jonathan EChairman & CEO06/08/2023275,000
Casdin Alexander W.Director04/10/202355,230
Lim Jonathan EChairman & CEO03/28/2023284,000
Chacko David M.Chief Financial Officer02/01/20237,169
Wei LinChief Medical Officer02/01/20237,169
Garner EbunGeneral Counsel & Corp. Sec.02/01/20239,791
Lim Jonathan EChairman & CEO01/10/2023231,420
Start Valerie Denise HardingDirector12/21/202246,400
Bristol James ArthurDirector12/21/202282,800
Chen BihuaDirector12/13/20221,999,998
Chen BihuaDirector12/13/20221,999,998
Casdin Alexander W.Director12/15/202297,490
Lim Jonathan EChairman & CEO12/14/2022199,600
Garner EbunGeneral Counsel & Corp. Sec.02/01/202211,486
Wei LinChief Medical Officer02/01/202218,123
Chacko David M.Chief Financial Officer02/01/202218,123
Chen BihuaDirector08/10/20214,420,000
Chen BihuaDirector07/26/20213,753,000
Chen BihuaDirector07/20/202115,200,000
Garner EbunGeneral Counsel07/20/202114,400
Start Valerie Denise HardingDirector07/20/202132,000
Multani Pratik SDirector07/20/202199,200
Hambleton JulieDirector07/20/202196,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ERASCA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.7,310,3210.0004%4.03%Other
RENAISSANCE TECHNOLOGIES LLC2,008,5000.00662%170.65%Other
GEODE CAPITAL MANAGEMENT, LLC1,811,9110.0004%5.63%Other
D. E. SHAW & CO., INC.102,2430.00019%NewOther
AQR CAPITAL MANAGEMENT LLC13,0580.00005%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR ERASCA INC
STOCK BUYBACKS FOR ERASCA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.19%
1Q
12/31/2023
06/30/2023
0.47%
2Q
12/31/2023
03/31/2023
0.83%
3Q
12/31/2023
12/31/2022
18.13%
4Q
12/31/2023
09/30/2022
24.78%
5Q
12/31/2023
06/30/2022
25.41%
6Q
12/31/2023
03/31/2022
26.15%
7Q
12/31/2023
09/30/2021
52.07%
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.19%
1Q
06/30/2023
0.47%
2Q
03/31/2023
0.83%
3Q
12/31/2022
18.13%
4Q
09/30/2022
24.78%
5Q
06/30/2022
25.41%
6Q
03/31/2022
26.15%
7Q
09/30/2021
52.07%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ERASCA INC
LOADING...